![Nicholas Sarlis: Dr Luis Raez succinctly describes recently reported results from key clinical trials in NSCLC patients](https://oncodaily.com/pub/uploads/2023/08/Nicholas-Sarlis-1-e1711908883936-1280x960.jpeg)
Photo from Nicholas Sarlis / LinkedIn
Apr 1, 2024, 12:55
Nicholas Sarlis: Dr Luis Raez succinctly describes recently reported results from key clinical trials in NSCLC patients
Nicholas Sarlis, Chief Medical Officer at CLEARA Biotech BV, shared a post on LinkedIn:
“Dr. Luis E Raez, a renowned lung cancer expert and eminent ex-collaborator, succinctly describes recently reported results from key clinical trials in NSCLC patients, namely PAPILLON, CHECKMATE 77T, and KEYNOTE-671. The VuMedi video below also provides the meaning of these recent NSCLC updates along with their ‘positioning’ across a complex and rapidly evolving therapeutic landscape.”
Proceed to the video.
Source: Nicholas Sarlis/LinkedIn